Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17910085 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Down Syndrome Memantine Follow-up Study
Conditions: Down Syndrome;   Intellectual Disability
Interventions: Drug: Memantine;   Drug: Placebo
2 Active, not recruiting Down Syndrome Biomarker Initiative (DSBI)
Conditions: Down Syndrome;   Alzheimer's Disease

Indicates status has not been verified in more than two years